The global demand for Pendred Syndrome Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Pendred syndrome refers to a genetic disorder that causes early hearing loss in children. Pendred syndrome is the most common syndromal form of deafness, is an autosomal recessive disorder connected with sensorineural hearing loss, developmental abnormalities of the cochlea, and diffuse thyroid enlargement. Pendred syndrome is defined as a condition typically distinguished by sensorineural hearing loss in both ears and euthyroid goiter. The amount of hearing loss differs among affected people. In numerous cases, significant hearing loss is there at birth. Pendred syndrome can be caused by mutations or changes in a gene called SLC26A4 (formerly called the PDS gene) on chromosome7.
Market Dynamics
The high prevalence of cases with a Family history of pendred syndrome and increasing financial support to the researchers for developing novel intervention is the major factor driving the pendred syndrome market. The rise in the demand for disease-specific novel treatment is stimulating high market demand. The Increase in the advancement in cochlear implantation and hearing kits is positively impacting market growth in the forecast period. Moreover, growth in the research and development activities in the market and a rise in the collaborations for product development are likely to create lucrative growth opportunities for key players of the pendred syndrome market in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pendred syndrome. The growth and trends of pendred syndrome industry provide a holistic approach to this study.
Market Segmentation
This section of the pendred syndrome market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Treatment
- Cochlear Implant
- Hearing Aids
- Radioactive Iodine
By Route Of Administration
By Diagnosis
- Genetic Testing
- Perchlorate Washout Test
- Others
By End Users
- Hospitals
- Homecare
- Specialty Clinics
- Otolaryngologist
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Pendred Syndrome market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Pendred Syndrome Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pendred syndrome market include Sensorion, Nobelpharma Co., Ltd, MED-EL Medical Electronics, Advanced Bionics AG, Cochlear Ltd, Sonova, GAES, Demant A/S, GN Store Nord A/S, Nurotron Biotechnology Co. Ltd, Audina Hearing Instruments, Inc, Amplifon, Elkon Pvt. Ltd, Starkey, Rion Co., Ltd, and others.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.